Page last updated: 2024-11-04

temozolomide and Disseminated Superficial Actinic Porokeratosis

temozolomide has been researched along with Disseminated Superficial Actinic Porokeratosis in 1 studies

Research Excerpts

ExcerptRelevanceReference
"We report a case of temozolomide (TMZ)-induced inflammation of disseminated superficial actinic porokeratosis (DSAP), an uncommon and pre-malignant cutaneous disorder."7.88Temozolomide-induced inflammation of disseminated superficial actinic porokeratosis. ( Gru, AA; Hamann, D; Kaffenberger, BH; Lee, DE, 2018)
"We report a case of temozolomide (TMZ)-induced inflammation of disseminated superficial actinic porokeratosis (DSAP), an uncommon and pre-malignant cutaneous disorder."3.88Temozolomide-induced inflammation of disseminated superficial actinic porokeratosis. ( Gru, AA; Hamann, D; Kaffenberger, BH; Lee, DE, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, DE1
Kaffenberger, BH1
Gru, AA1
Hamann, D1

Other Studies

1 other study available for temozolomide and Disseminated Superficial Actinic Porokeratosis

ArticleYear
Temozolomide-induced inflammation of disseminated superficial actinic porokeratosis.
    Dermatology online journal, 2018, Mar-15, Volume: 24, Issue:3

    Topics: Antineoplastic Agents, Alkylating; Biopsy; Dacarbazine; Humans; Inflammation; Male; Middle Aged; Por

2018